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Highlights 
 Protoporphyrin IX loaded Magnetoliposomes were produced small enough for 
intravenous application. 
 Protoporphyrin IX loaded Magnetoliposomes indicated its efficacy in nano-molar 
concentration for the in vitro photodynamic therapy application. 
 White LED light source provides sufficient energy to stimulate protoporphyrin 
molecules in cell culture. 
Abstract 
Background: Protoporphyrin IX (PpIX) is a well-known photosensitizer that has great potential 
for use in photodynamic therapy (PDT). However, aggregation behavior of PpIX in neutral 
water makes it inappropriate for physiological studies. PpIX-loaded magnetoliposomes (MLs) 
were fabricated to increase PpIX biocompatibility.  PpIX-loaded ML physical properties were 
characterized, and PpIX-loaded ML drug release behavior was investigated under the 
influence of an external magnetic field and heat. Toxicity and photodynamic effects of the 
complex were also examined using in vitro experiments with MCF-7 human breast cancer cells. 
Methods: The magnetoliposomes were prepared with DPPC, DSPE-PEG2000 lipids and Fe3O4 
nanoparticles. The toxicity and in vitro photodynamic effects of the PpIX-loaded MLs at various 
concentrations were studied using the MCF-7 cell line. 
Results: The produced PpIX-loaded MLs exhibited an average hydrodynamic diameter of 221 
nm; however, TEM measurements indicated that the diameter of the PpIX-loaded MLs varied 
between 166 and 720 nm. The iron content of the MLs affected cell viability less than the 
content of the iron free liposomes. Cell viability was reduced to 66% when the concentration 
of the PpIX-loaded MLs was 350 nM, but when white light was applied for 5 minutes, all of the 
cells that were exposed to concentrations of 250 nM and higher PpIX died within 24 hours.  
Conclusion: The results of this study demonstrated the effective application of PpIX-loaded 
MLs for in vitro photodynamic therapy at nanomolar concentrations. The results also indicated 
that an LED light source provided sufficient energy to stimulate the PpIX molecules.  
 
Keywords: Protoporphyrin IX, Magnetoliposomes, Iron oxide nanoparticles, Photodynamic 
therapy, MCF-7 cells 
 
INTRODUCTION 
Magnetoliposomes (MLs) consist of liposomes and magnetic nanoparticles. MLs have high 
potential for the delivery of various bioactive molecules that could be used for therapeutic 
applications in both humans and animals [1, 2]. Magnetic nanoparticles contribute 
multifunctional properties to MLs. For instance, MLs can be used as an image contrast agent, 
they can provide hyperthermic cancer treatment by heating nanoparticles in an alternating 
current electromagnetic field, and they can be used for liposomal drug delivery and 
thermosensitive drug release [3-5]. Diverse lipids, nanoparticles and drug combinations have 
been studied in the literature, and efficient incorporation of drugs into MLs has been shown 
to depend on the selection of lipids and nanoparticles, as well as on drug interactions [6-8]. 
Photodynamic therapy (PDT) uses photosensitizers and visible light to treat various types of 
cancer, such as lung, esophageal, gastric, cervical and bladder cancer. It is also used to treat 
non-malignant diseases, such as atherosclerosis, psoriasis, and age-related macular 
degeneration [9, 10]. Alone, photosensitizers and light are harmless, but cell damage results 
when they are combined in the presence of adequate molecular oxygen in tissue [11, 12]. 
When a photosensitizer is irradiated by an appropriate light wavelength, the photosensitizer 
is promoted from the ground state (S0) to the first excited singlet state (S1), and then it passes 
to the longer-lived triplet state (T1) by an intersystem crossing pathway. The excited 
photosensitizer returns to ground state from triplet state and either emits light called 
fluorescence or undergoes a radiationless transition, whereby energy is absorbed by or 
transferred to another particle or system [13]. In this process, the photosensitizer acts as an 
energy transducer and transfers energy to molecular oxygen, resulting in the production of 
many reactive oxygen species (ROS), such as singlet oxygen (1O2), hydrogen peroxide(H2O2), 
and superoxide radicals (O2-). Singlet oxygen (1O2) is a predominant cytotoxic agent in PDT [14-
16]. 
PDT is a clinically approved, minimally invasive therapeutic procedure. However, cancer 
patients may have medications remaining in their bodies for up to six weeks after 
administration, and their quality of life can be severely affected by PDT side effects. The most 
common side effects are mild to moderate burning, stinging, erythema and pain[17]. New 
drug research is continuing around the world to minimize these types of side effects and 
increase the use and efficacy of PDT[18]. 
Protoporphyrin IX (PpIX) is a metal-free porphyrin that is a precursor of heme. The 
biosynthesis of porphyrin starts with the synthesis of 5-aminolevulinic acid (5-ALA)[19, 20]. 
PpIX exists as a monomer in the pH range 0-3, as an aggregate in the pH range 3-8 and as a 
dimer in any pH greater than 8 [21]. Aggregation behavior of PpIX in neutral water makes it 
inappropriate for use in physiological studies. However, indirect application of PpIX is made 
possible by mediation with 5-ALA, which is a method that has been used for bladder cancer 
[22]. PpIX concentrations correlate with cellular 5-ALA concentration levels; therefore, 
concentrations of 5-ALA at the mM level have been examined in cell cultures [22, 23] 
We hypothesize that the usage of PpIX-loaded MLs in a cell line with PpIX concentrations lower 
than the concentration of 5-ALA-mediated PDT reported in literature can result in efficient 
therapeutic effects at nanomolar concentrations. Moreover, PpIX-loaded MLs can be used to 
for magnetic hyperthermia and for magnetic targeting because of the incorporated magnetic 
nanoparticles. The first aim of this study was first to fabricate PpIX-loaded MLs and 
characterize their structure. For structure characterization, we performed size and zeta 
potential measurements to understand ML hydrodynamic diameters and stability. We also 
examined magnetic hyperthermia over a series of temperature increments under an AC 
magnetic field. Turbidity testing was performed to assess magnetic targeting properties. The 
second aim of this study was to examine toxicity and photodynamic effects of PpIX-loaded 
MLs on the MCF-7 human breast cancer cell line, which represents one of the most aggressive 
forms of cancer. 
MATERIALS and METHODS 
Phospholipids 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) 
(DSPE-PEG2000) and an extruder set with 200-nm PC membranes were purchased from Avanti 
Polar Lipids (Alabaster, AL, USA). Fe3O4 nanoparticles with an average size of 10 nm in H2O and 
all other chemicals (including protoporphyrin IX), which were analytical grade and used 
without further purification, were purchased from Sigma-Aldrich (Sigma Chemical Company, 
Saint Louis, MO, USA).  
 Preparation of PpIX Stock Solution 
Stock solution was prepared by dissolving 1 mg PpIX in 5 ml of a chloroform-methanol mixture 
(2:1 (v/v)) and mixing well by vortexing. The stock solution was kept at +4 ºC after sealing the 
top of the container with parafilm. The stock solution was used within 5 days. 
 Preparation of PpIX-loaded Magnetoliposomes 
DPPC and DSPE-PEG2000 (99%:1% (w/w)) were dissolved in a mixture of chloroform and 
methanol (2:1 (v/v)) in a round-bottom flask. Different concentrations of PpIX (20 µM, 40 µM 
and 60 µM) were added to the phospholipid mixture and dried in a rotary evaporator 
(Heildolph Instrument, Schwabach, Germany) under reduced pressure at 50 °C to form a thin 
film on the inner surface of the flask. The thin film was hydrated by adding PBS while being 
rotated at 120 rpm at atmospheric pressure in a 60 °C water bath for 10 min. Then, the mixture 
was sonicated (Elmasonic E 100H, Singen, Germany) at 55-60 °C for 10 min. The resulting 
preparation was extruded 15 times through 200-nm polycarbonate membranes using the 
Avanti extruder set, and the PpIX-loaded liposomes were produced. Subsequently, different 
amounts of Fe3O4 nanoparticles (0.175, 0.35 and 0.5 mg Fe3O4) were prepared by mixing 1 
mlPBS 60 °C in an Eppendorf tube and adding PpIX-loaded liposomes. The mixture was 
sonicated for 15 min to obtain the PpIX-loaded magnetoliposomes (MLs). The PpIX-loaded 
MLs were dialyzed overnight using 20K Slide-A-Lyzer Dialysis Cassettes (Thermo Scientific, IL, 
USA) to remove unencapsulated PpIX and nanoparticles. Dialyzed and non-dialyzed samples 
were prepared to calculate encapsulation efficiency. Details can be found in the “Evaluation 
of PpIX Encapsulation and Release from Thermosensitive Magnetoliposomes” section of this 
manuscript. 
Magnetoliposome Preparation 
The magnetoliposome preparation procedure is similar to that of the PpIX-loaded MLs. The 
difference is that PpIX solution was not added to the phospholipid mixture, but 0.5 mg Fe3O4 
nanoparticles were added to obtain the MLs. The number of nanoparticles for ML preparation 
was chosen considering the zeta potentials of PpIX-loaded MLs experiment.  
 Liposome Preparation 
Liposomes were prepared using a procedure similar to that used for ML preparation, except 
the liposomes did not include Fe3O4 nanoparticles.  
Size and Zeta Potential Determination 
The zeta potentials and hydrodynamic diameters of the samples, including the mean and 
polydispersity of the samples, were determined by dynamic light scattering at 25 °C via 
Zetasizer Nano ZS (Malvern, UK).  
 
 
Transmission Electron Microscopy 
PpIX-loaded MLs and MLs were observed by transmission electron microscopy (TEM) using an 
FEI Tecnai G2Spirit BioTwin (Hillsboro, OR, USA) operating at 80 kV. The samples were 
prepared by casting a drop of ML dispersion onto a 200 mesh copper grid coated with carbon 
film and allowing it to air-dry before placing it into the microscope.  
Evaluation of PpIX Encapsulation and Release from Thermosensitive Magnetoliposomes 
The PpIX encapsulation and release assay was based on the detection of dialyzed and non-
dialyzed PpIX-loaded ML fluorescence; the procedure was modified from one previously 
published by Pradhan et al [3]. Dialyzed and non-dialyzed PpIX-loaded ML concentrations 
were used to calculate encapsulation instead of the initial PpIX concentration because initial 
PpIX was dissolved in chloroform and methanol, while PpIX-loaded MLs were in water, 
meaning a comparison may not yield reliable results. Encapsulation efficiency, percentage of 
PpIX release and the percentage of fluorescence emission were calculated (supplementary 
material). 
Measurement of Fe in PpIX-loaded MLs 
Inductively Coupled Plasma–Mass Spectrometer (ICP-MS) was used to investigate the amount 
of encapsulated Fe3O4 nanoparticles by measuring the Fe content of the PpIX-loaded MLs. For 
this purpose, 6 ml HNO3 and 2 ml H2O2 were added to samples and the temperature was 
increased to 175 °C over 15 min using a digestion microwave system (CEM, Mars5, NC, USA), 
and the mixture was held for another 15 min at that temperature for digestion. After that, 
samples were diluted, and Fe content was measured using ICP-MS (Agilent 7500ce, CA, USA). 
Dialyzed and non-dialyzed PpIX-loaded MLs having different amounts of Fe3O4 nanoparticles 
were compared to assess encapsulated iron content percentage.  
 
Measurement of PpIX-loaded ML Heating Ability under an Electromagnetic Field 
Assessment of PpIX-loaded ML heating ability was performed under an 8.947±2% µT, 50 Hz 
AC magnetic field generated by a solenoid. Magnetic field was measured by an Emdex II (CA, 
USA), and temperature changes were measured by a Fluke 568 infrared thermometer (WA, 
USA) with a wire probe. PpIX-loaded MLs were transferred to Eppendorf tubes and placed in 
the solenoid. An equal amount of water was also placed in the solenoid as a control for the 
heat generated by the solenoid. Temperature changes of the PpIX-loaded MLs and water were 
determined by measuring temperatures at 30 and 60 min under the electromagnetic field. 
Real temperature changes were obtained by subtracting the temperature of water from the 
temperature of the PpIX-loaded MLs.  
Turbidity Measurement 
Sedimentation stability and magnetic responses were determined by turbidity measurements 
in optical cuvettes using a spectrophotometer as previously described [24]. In brief, Fe3O4 
nanoparticles were diluted with ultrapure Milli-Q water and placed in glass cuvettes; every 5 
seconds up to 45 min, spectrophotometric measurements were collected at a wavelength of 
650 nm and were denoted as Ao650. Fe3O4 concentrations for both naked nanoparticles and 
PpIX-loaded MLs were same. Then, NE1816 permanent magnets (IBSmagnet, Berlin, Germany) 
were positioned symmetrically on the right and left side of the cuvette holder. Four magnets, 
with an average magnetic field property of 4T/m, were used on each side, and 
spectrophotometric measurements were performed as described above; these were defined 
as A650. The same measurements were repeated for the PpIX-loaded MLs. A graph illustrating 
time versus A650/ Ao650 was prepared to identify sedimentation stability and magnetic 
responses.  
 
Toxicity Study 
In vitro toxicity testing of the liposomes, the MLs and the PpIX-loaded MLs was performed 
using MCF-7 cells, which were obtained from Adnan Menderes University, Science Technology 
Research and Application Center, Aydin, Turkey. The cells were given DMEM supplemented 
with 10% fetal bovine serum and 1 mM sodium pyruvate and maintained at 37 °C in a CO2 
incubator containing 5% CO2. The cells were seeded at a density of 10,000 cells per well in a 
flat bottom 96-well plate, and media was refreshed after 24 hours. The PpIX-loaded MLs were 
diluted in complete media at different concentrations of PpIX, ranging from 25 nM to 350 nM, 
and added in wells. The same volume of MLs and liposomes were prepared at a variety of 
concentrations considering the volume of PpIX-loaded MLs added to the wells. After the 
addition of the liposomes, the MLs and the PpIX-loaded MLs into the wells, the cells were 
incubated again for 24 and 48 hours. Then, cell viability was assessed using an MTT assay kit 
(Roche, Germany). 
 In vitro PDT Study  
MCF-7 cell culture and preparation of liposomes, MLs and PpIX-loaded MLs is described above. 
After adding the samples to the cells, the cells were incubated for 3 hours and subsequently 
exposed to white diode light for 1, 3 and 5 min from a 3-cm height. Free PpIX dissolved in 0.5% 
DMSO was irradiated for 5 min. The LED downlight (20 W) was purchased from Epistar, 
Taiwan; the LED was 3000K white, 17 cm in application diameter and emitted 1650 lumens. 
The LED downlight was chosen because PpIX exhibits maximum absorbance at 409 nm light 
but also absorbs components at longer wavelengths in the visible light range[21], and white 
light contains all visible light, ranging from 400-700 nm. Furthermore, when considering the 
LED downlight properties and size, the heat generated by the light is very low and it is useful 
for the exposure of an entire 96-well plate. The cells were incubated again for 24 hours after 
sample addition; in other words, the cells were incubated for 21 hours after white light 
exposure. Subsequently, cell viability was determined by the MTT assay.  
 RESULTS  
 Characterization and Optimization of PpIX-loaded MLs 
The PpIX-loaded MLs appeared brown because of both the PpIX and the Fe3O4 nanoparticles. 
Increasing or decreasing the amount of either the PpIX or the Fe3O4 nanoparticles affected the 
color of the suspension, but the nanoparticles were inherently dominated the determination 
of sample color. The UV absorption spectrum of free PpIX, Fe3O4 nanoparticles and PpIX-
loaded MLs are shown in Figure 1. Concentration and lipid amount were constant for the 
entire experiment. To investigate Fe3O4 nanoparticle efficacy, different amounts of Fe3O4 
nanoparticles (0.175, 0.35 and 0.5 mg) were studied, while 20 µM PpIX was kept constant in 
PpIX-loaded ML preparation. As shown in Table 1, the PpIX-loaded ML average hydrodynamic 
diameter, polydispersity index (PDI) and zeta potential depended on the number of 
nanoparticles. 
High zeta potential (negative or positive) prevents magnetoliposome aggregation; therefore, 
0.5 mg Fe3O4 nanoparticles was selected for further study. To investigate the effect of PpIX on 
size and zeta potential, a variety of PpIX concentrations (20, 40 and 60 µM) were used to 
prepare the PpIX-loaded MLs while keeping the amount of Fe3O4 nanoparticles constant at 0.5 
mg. Average size, PDI and zeta potential changes are shown in Table 2. 
TEM analyses were performed without staining the samples. The ML sizes were smaller than 
200 nm, whereas PpIX-loaded ML size varied between 166 and 720 nm (Figure 2). TEM images 
show the color of the PpIX-loaded MLs to be darker compared to the MLs, and when the PpIX-
loaded MLs were 200 nm or smaller, they were quite dark and perfectly spherical (Figure 2D).  
 
Iron Content of PpIX-loaded MLs 
The calculated non-dialyzed PpIX-loaded ML Fe content was approximately 1.7 times higher 
than the Fe content measured by ICP-MS, and linear increments existed in both the calculated 
and the measured values. The percentage of encapsulated Fe3O4 nanoparticles in dialyzed 
samples was 83.96% for the 0.175 mg initial nanoparticle addition, 91.67% for the 0.35 mg 
initial nanoparticle addition and 80.85% for the 0.5 mg initial nanoparticle addition; these 
were calculated by comparing the percentage of Fe content between dialyzed and non-
dialyzed samples. 
Encapsulation Efficiency 
Dialyzed and non-dialyzed PpIX-loaded MLs were used to calculate the percentage of PpIX 
encapsulation depending on fluorescence emission; therefore, the percentage of 
encapsulation is also the encapsulation efficiency of dialyzed samples, which is shown in 
Figure 3A. The mean values of PpIX encapsulation percentage for 20 µM and 40 µM PpIX-
loaded MLs were similar; they were 65.55±2.09 and 67.65±1.93, respectively. In contrast, the 
PpIX encapsulation percentage of 60 µM PpIX-loaded MLs was calculated as 81.65±1.05.  
The PpIX encapsulation percentages were multiplied by the initial concentrations of PpIX, 
which were used for fabricating the PpIX-loaded MLs, to obtain the concentration of 
encapsulated PpIX (Figure 3B). Although percent fluorescence intensities similar for PpIX(20) 
and PpIX(40), PpIX(40) concentration was almost twice that of PpIX(20) because dialyzed and non-
dialyzed PpIX-loaded MLs were used to calculate the concentrations. Considering all these 
results (size, zeta potential, fluorescence emission etc.) and the volume of PpIX-loaded MLs to 
be applied to cell culture, PpIX(40) was chosen for further experiment.  
 
 
Temperature Effects 
The percentage of PpIX release at different temperatures (37 °C and 42 °C) within 1 hour 
indicated that PpIX release at 42 °C at any time was lower than that of 37 °C, which was not 
rational (supplementary material Figure 1A). It should not be related to the release of PpIX, 
but to the aggregation of highly released PpIX. Fluorescence intensity percentages indicated 
fluorescence emission of PpIX for different temperatures (supplementary material Figure 
1B,C). 
Temperature changes of PpIX-loaded MLs under an Electromagnetic field 
Temperature changes were observed for both water and PpIX-loaded MLs under AC magnetic 
field. Effect of PpIX-loaded MLs on temperature changes were obtained by subtracting the 
temperature of the water from the temperature of the PpIX-loaded MLs. Temperature of the 
PpIX-loaded MLs increased by 0.9oC within 30 min and by 1.5oC within 60 min under an 
8.947±2% µT AC electromagnetic field. 
Turbidity Assessment 
There was almost no sedimentation observed during turbidity measurements for the PpIX-
loaded MLs, but almost 10% sedimentation was observed for the Fe3O4 nanoparticles within 
45 min. However, under the effect of permanent magnets, small amounts of nanoparticles 
accumulated on the cuvette walls where the magnets were positioned. Cuvette wall 
accumulation was highest for the PpIX-loaded MLs, leading to decreased absorbance A650/ 
Ao650 rates (Figure 4).  
Toxicity Analysis 
Viability of cells that did not receive light exposure (dark toxicity) was evaluated using the MTT 
assay. Percentages of viable cells after 24 hours and 48 hours were shown in Figure 5A and 
5B. Average viability of cells that received the highest PpIX-ML concentrations (V350) were 66% 
after 24 hours and 55% after 48 hours. 
In vitro PDT Results 
Cell viability after receiving liposomes and ML groups with 1, 3 and 5 min of irradiation was 
similar to viability of cells incubated for 24 hours without having received light exposure. In 
the PpIX-loaded ML group, cell viability decreased with increasing irradiation time (Figure 6). 
After 5 min of irradiation, cell viabilities were determined to be 0% for PpIX-ML concentrations 
of 250 nM and higher and slightly higher for free PpIX, but the difference was not significance 
(p>0.05) because of the high standard error of the free PpIX data. Slightly higher cell viability 
with the free PpIX may have been caused by the relatively low stimulation of aggregated PpIX 
molecules. Although PpIX dissolves in 100% DMSO, absorbance rate decreases when the ratio 
of DMSO in PBS decreases (Figure 7), which may be the result of aggregation. Only 350 nM 
PpIX concentrations caused 0% cell viability after 3 min of irradiation. Experiments with longer 
periods of light irradiation were also performed. When the light exposure time exceeded 10 
min, the cells containing concentrations of PpIX in MLs of 150 nM and higher, cell viability was 
found to be 0% (data not shown). 
DISCUSSION 
Liposomes have been frequently used as targeted drug delivery agents. Liposomes or particles 
must be smaller than 5 µm to be delivered in the bloodstream because the smallest capillaries 
in the body have a 5-6 µm radius, and the use of larger liposomes or particles may result in 
embolism [16]. PpIX(40)-loaded MLs (dialyzed) were 221.8±0.8 nm in size with a 0.331 PDI 
dynamic light scattering (DLS) measurement, which indicated that the samples had a good 
quality size distribution and were small enough for intravenous administration. However, TEM 
images showed that the sizes of the PpIX(40)-loaded MLs (dialyzed) were between 166 and 720 
nm. We think that some of the closely aggregated PpIX molecules may have gathered lipids 
around the aggregate surfaces, leading to larger or multi-lamellar PpIX-loaded MLs. PpIX may 
be responsible for aggregation-dependent size increments because the MLs were smaller than 
200 nm, and the only difference between the MLs and the PpIX-loaded MLs was PpIX. 
However, one possible reason for observing larger sizes of PpIX-loaded MLs is that this may 
be an effect of the drying process on the TEM grid. PpIX is a hydrophobic molecule; hence, it 
most likely formed lipid bilayers, and the Fe3O4 nanoparticles were likely located in the center 
of the vesicles. The nanoparticles demonstrated hydrophilic properties because they were 
observed to be stable in water. When the PpIX-loaded MLs were 200 nm or smaller, the 
vesicles were almost perfectly spherical, which suggested that 200 nm was a critical diameter 
for obtaining a spherical shape. However, cryo-TEM analysis would be more helpful in 
determining the relative locations of the PpIX and the nanoparticles in the lipid bilayers as well 
as the factors affecting PpIX-loaded ML size and shape. 
Concerning the encapsulation of the iron oxide nanoparticles in the PpIX-loaded MLs, the 
highest rate of Fe content was observed to be 91.67% for the dialyzed sample with the initial 
addition of 0.35 mg Fe3O4 nanoparticles. However, the highest amount of encapsulated 
nanoparticles was obtained by the sample that received the highest initial amount of 
nanoparticles, 0.5 mg Fe3O4 nanoparticles (80.85% Fe content). Frascione et al.[25] reported 
a highest encapsulation efficiency of 92% for a sample that received MLs with an initial Fe 
concentration of 0.5 mg/ml, which were produced for magnetic resonance imaging.  
The percentage of PpIX encapsulation was almost the same for PpIX(20) and PpIX (40), whereas 
PpIX(60) had approximately 14% higher PpIX encapsulation in comparison with the other PpIX-
loaded ML groups; this may have resulted from fluorescence emission of unencapsulated but 
aggregated PpIX. Although PpIX (40) had two times more initial PpIX than PpIX(20), similar 
percentages of encapsulation efficiency were observed.  
Temperature dependent percentage of PpIX release cannot be calculated by the %release 
formula as reported by Pradhan et al.[3] for this experiment because released PpIX molecules 
aggregate in neutral water. As a result of this aggregation, only the outer surface of aggregated 
molecules might be stimulated by light and fluoresce. Therefore, fluorescence intensities of 
PpIX at 42 °C were observed to be smaller or slightly higher than fluorescence intensities at 
t=0, which is not possible because the transition temperature of lipids is lower than 42 °C.  
Percentage of fluorescence intensity for dialyzed PpIX-loaded MLs in decreasing order were 
PpIX(20)>PpIX(40)>PpIX(60). However, this result was not directly proportional to the amount of 
encapsulated PpIX, but was also influenced by the release rate of PpIX from the MLs and PpIX 
aggregation behavior. This result indicates that when PpIX molecules release rapidly, 
aggregation occurs. Therefore, we suggest that relatively slow release of PpIX at body 
temperature is more favorable. 
Temperature changes of PpIX-loaded MLs under a low frequency AC magnetic field revealed 
that when the PpIX-loaded MLs were administered at body temperature, 50 Hz 
electromagnetic fields only caused a 1°C change within 30 min. However, Kulshrestha et 
al.[26] reported that temperature of paclitaxel-loaded MLs rose from 25°C to 43°C within 30 
min using a magnetic field with a 10-kA current and a 423-kHz frequency. Another report, 
published by Pradhan et al.[3], demonstrated that the temperature of folate-targeted MLs 
reached 42.5oC within 15 min under a magnetic field with a 12-kA current and 290-kHz 
frequency. According to these results, high frequency and high current are needed to increase 
the temperature of MLs in a short time.  
The purpose of the magnetic response assessment was to understand whether the vehicle is 
suitable for targeted, magnetic drug delivery applications. Magnetic response of the PpIX-
loaded MLs was dependent on the magnetic properties and number of encapsulated magnetic 
nanoparticles. Although the PpIX-loaded MLs exhibited a 63% magnetic field response within 
45 min, the response was not sufficient for magnetic targeting; as suggested by Vlaskou et 
al.[24], response needs to be 90% or higher. However, the response of the PpIX-loaded MLs 
to the magnetic field was higher than that of the nanoparticles, which exhibited approximately 
a 25% response to the magnetic field. It should also be noted that the PpIX-loaded MLs 
demonstrated no sedimentation within 45 min, which may be the result of their zeta 
potentials. 
In view of the cytotoxic effects exerted by the liposomes, the MLs and the PpIX-loaded MLs at 
the highest concentrations, cell viability for all groups was observed to be higher than 63% 
after 24 hours of incubation and higher than 55% after 48 hours of incubation. The toxic effect 
of the liposomes was observed to be slightly higher than that of the MLs and the PpIX-loaded 
MLs after both 24 and 48 hours of incubation. Soenen et al. [27] reported similar results for 
3T3 fibroblasts and explained that the slight protective effect was due to stable ML formation. 
These results suggested to us that lipid formation affects cell viability more than the number 
of nanoparticles used in this study, and it is likely that the stable nanoparticle-lipid formation 
was responsible for this slightly lower toxicity. The reduction of cell viability could be due to 
the reactive oxygen species. 
In previous studies, ALA-induced PpIX in cell culture was used with a range of ALA 
concentrations, which varied between 20 µM and 1 mM [28, 29]. The concentration of PpIX 
that we used was at the nM level, and results indicate that direct usage of PpIX via MLs can 
yield effective results at very low concentrations (approximately 60 fold smaller than the ALA 
concentration). 
Red lasers are usually used in PDT studies because tissue penetration of red is higher than the 
smaller wavelengths of visible light [30]. However, the absorbance wavelength of 
photosensitizers has to be considered to use them effectively for PDT. PpIX indicates 
maximum absorbance with approximately 400-nm light. It has been reported that the 
application of a 20-µM hexenyl ester of ALA and a 5-J/cm2 red LED resulted in an 
approximately 80% MCF-7 cells survival rate after 24 hours of incubation [28]. Fratz et al.[31] 
have used ALA-induced PpIX in a variety of cell lines, and they used red light (630 ± 20 nm) to 
measure toxicity. They found that toxicity changes depending on cell type (80%-30%). We 
think that application of 400-nm light would result in higher toxicity for PDT using mediated 
ALA-induced PpIX. Therefore, we used white light, which contains light between 400 nm to 
780 nm. Similarly, Tachikawa et al.[32] produced PpIX-lipid micelles and applied these to Hela 
cells. The Hela cells were irradiated with a xenon lamp in the 400-800 nm wavelength range, 
and they also obtained toxicity using nM levels of PpIX. Additionally, Temizel et al.[33] used 
375 nm light to irradiate liposomal porphyrin. Therefore, according to all these reports, PpIX 
requires approximately 400-nm light to yield maximum efficiency. However, deep tissue 
efficacies of PpIX with white light in cancer therapy should be examined closely.  
In our study, significant reduction in cell viability was observed depending on the amount of 
irradiation time received by the MCF-7 cells. When the light exposure had exceeded 10 min, 
all the cells exposed to 150 nM and higher concentrations of PpIX died, which should be the 
result of singlet oxygen production and/or other ROS. These in vitro results represent that the 
PpIX-loaded MLs that we produced are highly effective for PDT and that they enable the use 
of inexpensive, harmless white light instead of relatively expensive, high-energy lasers. 
CONCLUSİON 
 In the present study, we prepared PpIX-loaded MLs and studied their drug release behavior, 
toxicity and photodynamic effects. The results of the current study revealed that PpIX-loaded 
MLs produced are small enough for intravenous application and that aggregation behavior can 
be eliminated by regulating zeta potentials. When nano-molar concentrations of PpIX-loaded 
MLs were irradiated by LED white light, 100% cell death was caused in the MCF-7 cell line, 
which is one of the aggressive breast cancer cell lines. As a result, this study demonstrates 
that PpIX-loaded MLs are highly effective and promising structures for PDT. Furthermore, the 
PpIX-loaded ML has potential to be used in magnetic resonance imaging because of the iron 
oxide nanoparticle content and is also a suitable structure for targeted therapy. However, 
future in vivo studies should be carried out to determine the behavior of the PpIX-loaded MLs 
in physiological environments. 
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Table 1. Hydrodynamic diameter (size), polydispersity index (PDI) and zeta potential of 
dialyzed and non-dialyzed PpIX-loaded MLs. The values are shown as the mean ± standard 
deviation for each group (n=3). Concentration of PpIX was constant as 20 μM and different 
amounts of Fe3O4 nanoparticles (0.175, 0.35 and 0.5 mg) were used to produce the PpIX-
loaded MLs.  
Name of Sample 
Size (nm) 
Mean[R:max-min]   
(PDI) 
Mean±StdDev 
Zeta Potential 
(mV) 
Mean±StdDev 
ML-PpIX(20)- (0.175 mg Fe3O4)  169.1 [3.4]  (0.164 ± 0.008) -5.3 ± 1.1 
ML-PpIX(20)-(0.175 mg Fe3O4)-
Dialyzed  
178.4 [2.7]  (0.178 ± 0.008) -8.1 ± 0.6 
ML-PpIX(20) -(0.35 mg Fe3O4)  174.5 [9.5]   (0.188 ± 0.017) -10.4 ± 0.8 
ML-PpIX(20)-(0.35 mg Fe3O4)- 
Dialyzed 
207.8 [6.3] (0.323 ± 0.047) -9.53 ± 0.4 
ML-PpIX(20)-(0.5 mg Fe3O4) 166.0 [4.0]  (0.155 ± 0.019) -11.1 ± 0.2 
ML-PpIX(20)-(0.5 mg Fe3O4)- Dialyzed 211.0 [18.4] (0.380 ± 0.023) -10.8 ± 1.2 
Table 2. Size, PDI and zeta potential of dialyzed and non-dialyzed PpIX-loaded MLs. The 
values are shown as the mean ± standard deviation for each group (n=3). PpIX-loaded MLs 
were synthesized with 0.5 mg Fe3O4 nanoparticles for each group. Different concentrations 
of PpIX (20, 40 and 60 µM) were used to produce the PpIX-loaded MLs.  
Name of Sample 
Size (nm)  
Mean[R:max-min]    
(PDI) 
Mean±StdDev 
Zeta Potential 
(mV) 
Mean±StdDev 
ML-PpIX(20) 166.0 [4.0]  (0.155 ± 0.019) -11.1 ± 0.2 
ML-PpIX(20)-Dialyzed 211.0 [18.4] (0.380 ± 0.023) -10.8 ± 1.2 
ML-PpIX(40) 166.1 [9.8]   (0.130 ± 0.025) -11.9 ± 1.3 
ML-PpIX(40)-Dialyzed 221.8 [1.6]  (0.331 ± 0.040) -10.8 ± 0.9 
ML-PpIX(60) 164.2 [2.9]  (0.200 ± 0.011) -9.28 ± 0.5 
ML-PpIX(60)-Dialyzed 230.6 [28.9] (0.394 ± 0.019) -7.78 ± 0.3 
 
 
  
 
 
  
 
  
